The crimson papers are a series of short documents aimed at sharing knowledge regarding the process of scheduling plants, medicines and substances within the international drug control treaty framework.

The crimson papers

#2

The committee

Basics about the Expert Committee on Drug Dependence of the World Health Organization.

Full version of the paper in PDF

FAAAT Crimson paper #2 – The committee.

Download the full text

  Authors:
GHEHIOUECHE Farid
KRAWITZ Michael
RIBOULET ZEMOULI Kenzi

Paris, Septembre 2017.

FAAAT think & do tank Editions
PARIS 75011, 8 RUE DU GÉNÉRAL RENAULT
ISBN 979-10-97087-01-2
EAN 9791097087012

Among the few roles mandated by the international drug control conventions, the World Health Organization (WHO) must carry the task of evaluating substances liable to produce harms or dependence, in order to decide the most accurate level of control to apply.

It is one of the few tasks of WHO, if not the only one, mandated by the drug control treaties.

That labour is handled by a body of independent experts, the Expert Committee on Drug Dependence (ECDD), responsible for conducting the medical and scientific evaluation of substances provoking dependence, and liable to abuse and to create “ill-effects”.

Their scientific reviews result in the issuing of recommendations to the main international legislative body on drug-related questions: the Commission on Narcotic Drugs (CND).

No “narcotic drug” or “psychoactive substance” can be placed under or withdrawn from the rules of the international drug control treaties without having received a previous evaluation and abuse liability assessment by the Expert Committee on Drug Dependence of the WHO.

This paper will briefly explore both the role and history of the committee, and sketch the main principles and practices that rule the functioning of this ECDD.

Full version of the paper in PDF

FAAAT Crimson paper #2 – The committee.

Download the full text